Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation

被引：3
作者：
Wood, Brian R. [1 ]
Kassaye, Seble G. [2 ]
Gerstoft, Jan [3 ]
机构：
[1] Univ Washington, Div Allergy & Infect Dis, Seattle, WA USA
[2] Georgetown Univ, Dept Med, Washington, DC USA
[3] Univ Copenhagen, Dept Infect Dis, Rigshosp, Copenhagen, Denmark
来源：
AIDS | 2023年 / 37卷 / 04期
关键词：
RILPIVIRINE; FAILURE;
D O I：
10.1097/QAD.0000000000003476
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：689 / 691
页数：3
相关论文
共 50 条
  • [41] Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South
    Collins, Lauren F.
    Corbin-Johnson, Della
    Asrat, Meron
    Morton, Zoey P.
    Dance, Kaylin
    Condra, Alton
    Jenkins, Kimberly
    Todd-Turner, Marie
    Sumitani, Jeri
    Smith, Bradley L.
    Armstrong, Wendy S.
    Colasanti, Jonathan A.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
  • [42] Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort
    De Vito, Andrea
    Botta, Annarita
    Berruti, Marco
    Castelli, Valeria
    Lai, Vincenzo
    Cassol, Chiara
    Lanari, Alessandro
    Stella, Giulia
    Shallvari, Adrian
    Bezenchek, Antonia
    Di Biagio, Antonio
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (02):
  • [43] Long-Acting Anti-HIV Drugs Targeting HIV-1 Reverse Transcriptase and Integrase
    Singh, Kamal
    Sarafianos, Stefan G.
    Sonnerborg, Anders
    PHARMACEUTICALS, 2019, 12 (02)
  • [44] Human Immunodeficiency Virus Type 1 RNA Levels in Rectal and Seminal Compartments After Switching to Long-Acting Cabotegravir Plus Rilpivirine: A Longitudinal Study
    Masia, Mar
    Fernandez-Gonzalez, Marta
    Agullo, Vanesa
    Mascarell, Paula
    Padilla, Sergio
    Garcia-Abellan, Javier
    Gutierrez, Felix
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E748 - E751
  • [45] Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real-world setting in Belgium
    Nasreddine, Rakan
    Yombi, Jean Cyr
    Darcis, Gilles
    Florence, Eric
    Allard, Sabine D.
    De Scheerder, Marie-Angelique
    Henrard, Sophie
    Demeester, Remy
    Messiaen, Peter
    Ausselet, Nathalie
    Loeckx, Matthias
    Delforge, Marc
    De Wit, Stephane
    HIV MEDICINE, 2023, 24 (03) : 267 - 278
  • [46] Selection of Rilpivirine-Resistant HIV-1 in a Seroconverter From the SSAT 040 Trial Who Received the 300-mg Dose of Long-Acting Rilpivirine (TMC278LA)
    Penrose, Kerri J.
    Parikh, Urvi M.
    Hamanishi, Kristen A.
    Else, Laura
    Back, David
    Boffito, Marta
    Jackson, Akil
    Mellors, John W.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (06) : 1013 - 1017
  • [47] Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments
    Aparicio, Laura-Amanda Vallejo
    Garcia, Victoria Neches
    Hernandez-Novoa, Beatriz
    Casado, Gregorio
    Jodar, Ferran
    Pinel, Marco
    Velasco, Daniel Callejo
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [48] Virologic Failure and Emergent Integrase Strand Transfer Inhibitor Drug Resistance With Long-Acting Cabotegravir for HIV Treatment: A Meta-analysis
    Navarro, Andrea Perez
    Nutt, Cameron T.
    Siedner, Mark J.
    Mccluskey, Suzanne M.
    Hill, Andrew
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [49] Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting AntiRetroviral Drugs for Treating HIV-1
    Nischang, Marc
    Sutmuller, Roger
    Gers-Huber, Gustavo
    Audige, Annette
    Li, Duo
    Rochat, Mary-Aude
    Baenziger, Stefan
    Hofer, Ursula
    Schlaepfer, Erika
    Regenass, Stephan
    Amssoms, Katie
    Stoops, Bart
    Van Cauwenberge, Anja
    Boden, Daniel
    Kraus, Guenter
    Speck, Roberto F.
    PLOS ONE, 2012, 7 (06):
  • [50] Safety and Efficacy of Long-Acting Injectable Agents for HIV-1: Systematic Review and Meta-Analysis
    Wang, Wenjing
    Zhao, Shengnan
    Wu, Yaxin
    Duan, Wenshan
    Li, Sibo
    Li, Zhen
    Guo, Caiping
    Wang, Wen
    Zhang, Tong
    Wu, Hao
    Huang, Xiaojie
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
12345